Search results
Showing 1 to 10 of 10 results for mifepristone
This guideline covers care for women of any age (including girls and young women under 18) who request an abortion. It aims to improve the organisation of services and make them easier for women to access. Detailed recommendations on conducting abortions at different gestational stages are also included, to ensure that women get the safest and most effective care possible.
Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126)
This guideline covers diagnosing and managing ectopic pregnancy and miscarriage in women with complications, such as pain and bleeding, in early pregnancy (that is, up to 13 completed weeks of pregnancy). It aims to improve how early pregnancy loss is diagnosed, and the support women are given, to limit the psychological impact of their loss.
This guideline covers the circumstances for inducing labour, methods of induction, assessment, monitoring, pain relief and managing complications. It aims to improve advice and care for pregnant women who are thinking about or having induction of labour.
Question What is the effectiveness and safety of regimens using mifepristone and misoprostol for women who are having medical abortion...
was evidence that osmotic dilators are less acceptable to women than mifepristone or misoprostol. In addition, the evidence comparing...
women up to and including 9+0 weeks' gestation at the time they take mifepristone with women who take it between 9+1 and 10+0 weeks, the...
This quality standard covers care for women of any age (including girls and young women under 18) who request an abortion. It describes high-quality care in priority areas for improvement.
View quality statements for QS199Show all sections
Sections for QS199
- Quality statements
- Quality statement 1: Access to abortion services
- Quality statement 2: Choice of abortion procedure
- Quality statement 3: Waiting time for an abortion
- Quality statement 4: Early medical abortion
- Quality statement 5: Contraception
- Quality statement 6: Support after an abortion
- Update information
This evidence summary has been updated and replaced by NICE guideline NG207.
NG140/6 | What is the effectiveness and safety of regimens using mifepristone and misoprostol for women who are having medical abortion...
NICE recommends offering women induced labour earlier in new draft guidance
Women should be offered induced labour earlier than previously advised to make birth safer for them and their babies, according to draft guidelines published by NICE today (25 May 2021). The updated recommendations strengthen previous advice in the light of new evidence on induction timings.